OpalGenix
OpalGenix is dedicated to enhancing pain management by minimizing opioid risks and maximizing surgical pain relief through personalized, evidence-based technology. Their flagship product, GPS-Opioid™, utilizes pharmacogenetic testing and intelligent analytics to guide precise opioid selection and dosing, aiming to improve patient safety and clinical outcomes.
What We Do
GPS-Opioid™ is a pre-operative laboratory-developed test that incorporates a pharmacogenetic panel and intelligent analytics to guide personalized opioid selection, precision dosing, and tailored prescribing. It aims to maximize surgical pain relief while minimizing opioid-related patient safety risks.
Application Area
Battlefield Resuscitation
Digital Health Technologies
Key People
Founder & Chief Medical Officer
Chief Executive Officer
Chairman of the Board
Member of the Board